Charting the Course: Use of Clinical Pathways to Improve Value in Cancer Care

J Clin Oncol. 2020 Feb 1;38(4):367-371. doi: 10.1200/JCO.19.01482. Epub 2019 Dec 5.
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / economics*
  • Antineoplastic Agents / therapeutic use
  • Cost-Benefit Analysis
  • Drug Costs
  • Health Care Costs
  • Humans
  • Neoplasms / drug therapy
  • Neoplasms / economics*
  • Neoplasms / therapy*
  • United States

Substances

  • Antineoplastic Agents